Clinical Trial Update: Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 interventional clinical trial evaluating CCSVI treatment in patients with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of British Columbia | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED